Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi.
Regulation of the synthesis of Vi polysaccharide, a major virulence determinant in Salmonella enterica serotype Typhi, is under the control of two regulatory systems, ompR-envZ and rscB-rscC, which respond to changes in osmolarity. Some serotype Typhi strains exhibit overexpression of Vi polysaccharide, which masks clinical detection of lipopolysaccharide O antigen. This variation in Vi polysaccharide and O antigen display (VW variation) has been observed since the initial studies of serotype Typhi. In this study, we report that rpoS plays a role in this increased expression in Vi polysaccharide. We constructed a variety of isogenic serotype Typhi mutants that differed in their expression levels of RpoS and examined the role of the rpoS product in synthesis of Vi polysaccharide under different osmolarity conditions. Vi polysaccharide synthesis was also examined in serotype Typhi mutants in which the native promoter of the rpoS was replaced by an araCP(BAD) cassette, so that the expression of rpoS was arabinose dependent. The RpoS(-) strains showed increased syntheses of Vi polysaccharide, which at low and medium osmolarities masked O antigen detection. In contrast, RpoS(+) strains showed lower syntheses of Vi polysaccharide, and an increased detection of O antigen was observed. During exponential growth, when rpoS is unstable or present at low levels, serotype Typhi RpoS(+) strains overexpress the Vi polysaccharide at levels comparable to those for RpoS(-) strains. Our results show that RpoS is another regulator of Vi polysaccharide synthesis and contributes to VW variation in serotype Typhi, which has implications for the development of recombinant attenuated Salmonella vaccines in humans.
Santander
Javier
J
The Biodesign Institute, Center for Infectious Diseases and Vaccinology, Arizona State University, PO Box 875401, 1001 S. McAllister Avenue, Tempe, AZ 85287-5401, USA.
Wanda
Soo-Young
SY
Nickerson
Cheryl A
CA
Curtiss
Roy
R
D001426:Bacterial Proteins / Q000502:physiology*; D015195:Drug Design; D019081:O Antigens / Q000378:metabolism; D011135:Polysaccharides, Bacterial / Q000096:biosynthesis* / Q000235:genetics; D012485:Salmonella typhi / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D012808:Sigma Factor / Q000502:physiology*; D014613:Vaccines, Attenuated / Q000138:chemical synthesis / Q000235:genetics; D014614:Vaccines, Synthetic / Q000737:chemistry / Q000235:genetics
D001426:Bacterial Proteins; D019081:O Antigens; D011135:Polysaccharides, Bacterial; D012808:Sigma Factor; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic; C054154:capsular polysaccharide, Salmonella; C069567:sigma factor KatF protein, Bacteria